Metastatic breast cancer: Endocrine therapy landscape reshaped

por Mohamad Adham Salkeni, Samantha June Hall
Publicado 2017

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-W...

por Li Y, Xie Y, Gong C, Zhao Y, Zhang J, Zhang S, Wang L, Chen S, Hu X, Wang B
Publicado 2020

Are another 5 years of adjuvant aromatase inhibitor therapy needed?

por Mo QG, Li DQ, Zhong JH, Wei CY
Publicado 2016

Resistance and Overcoming Resistance in Breast Cancer

por Luque-Bolivar A, Pérez-Mora E, Villegas VE, Rondón-Lagos M
Publicado 2020

Adjuvant systemic therapy in older women with breast cancer

por Leone J, Leone BA, Leone JP
Publicado 2016

Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma

por Andrea Magali González-Mora, Patricia Garcia-Lopez
Publicado 2021

The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer

por Yi-Kun Kang, Xue Wang, Nan-Lin Hu, Jian Yue, Yi-Ran Si, Jie Ju, Song-Lin Gao, Peng Yuan
Publicado 2021

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India

por Butani D, Gupta N, Jyani G, Bahuguna P, Kapoor R, Prinja S
Publicado 2021

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer

por Hyder T, Bhattacharya S, Gade K, Nasrazadani A, Brufsky AM
Publicado 2021

Association of Endocrine Therapy and Dementia in Women with Breast Cancer

por Thompson MR, Niu J, Lei X, Nowakowska M, Wehner MR, Giordano SH, Nead KT
Publicado 2021

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer

por Isabel Grote, Stephan Bartels, Leonie Kandt, Laura Bollmann, Henriette Christgen, Malte Gronewold, Mieke Raap, Ulrich Lehmann, Oleg Gluz, Ulrike Nitz, Sherko Kuemmel, Christine zuEulenburg, Michael Braun, Bahriye Aktas, Eva‐Maria Grischke, Claudia Schumacher, Kerstin Luedtke‐Heckenkamp, Ronald Kates, Rachel Wuerstlein, Monika Graeser, Nadia Harbeck, Matthias Christgen, Hans Kreipe
Publicado 2021

Biological features of ductal carcinoma in situ: clinical role and basis for treatment individualization

por Irina V. Kolyadina, Anastasia S. Butrimova, Irina V. Poddubnaya, Vlada V. Kоmetova, Valery V. Rodionov
Publicado 2021

Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice

por Irina V. Kolyadina, Natalia R. Abidova, Arshak A. Akopyan, Galina V. Antonova, Oksana I. Arapova, Elvira A. Bobrova, Larisa V. Bolotina, Chulpan K. Valiakhmetova, Anna V. Vasilevskaya, Lyubov Y. Vladimirova, Mikhail V. Volkonskiy, Inna P. Ganshina, Irina E. Gudkova, Alexandr S. Dergunov, Irina V. Evstigneeva, Viktoria S. Egurenkova, Aleksei V. Emshanov, Lyudmila G. Zhukova, Elena V. Zueva, Elena V. Karabina, James J. Kolokolov, Svetlana V. Kuzmicheva, Olesya A. Kuchevskaya, Ivan A. Luev, Ksenia S. Maistrenko, Elena V. Markizova, Vasily V. Marfutov, Sergey P. Medvedev, Yulia I. Merzlikina, Tatyana A. Nersesova, Elena G. Ovchinnikova, Svetlana A. Orlova, Natalia Y. Samaneva, Olesya A. Stativko, Anna E. Storozhakova, Daniil L. Stroyakovskiy, Alexander V. Sultanbaev, Asiat I. Tekeeva, Natalia V. Fadeeva, Alina N. Fedorova, Oksana M. Shalaeva, Irina A. Shangina, Oksana N. Shirokova, Alisa R. Shumskikh, Mariam Z. Yakubova
Publicado 2021